Article
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.
Medicine - 9 Jun 2023
Chang Xueliang, Wang Hu, Yang Zhan, Wang Yaxuan, Li Jingdong, Han Zhenwei
Abstract excerpt
BACKGROUND: This meta-analysis was performed to address the association of 2 ESR2 gene polymorphisms (rs1256049 and rs4986938) with susceptibility to cancer. METHODS: An extensive literature search for eligible candidate gene studies published before May 10, 2022, was conducted in PubMed, Medline, and Web of Science. The search strategy was as follows: (ESR2 OR ERβ OR ER beta OR estrogen receptor beta) AND...
Topics
Join the communities discussing this publication.
